Geisel School of Medicine Board of Overseers

Keith R. Dunleavy, MD

Chief Executive Officer and Chairman of the Board

Dr. Dunleavy has served as Inovalon's (NASDAQ: INOV) Chief Executive Officer since his organization of the company's predecessor companies in 1998, as Chairman of the board of directors since the creation of the board in 2006, and as President from the Company's foundation until May 2014. Dr. Dunleavy oversees the overall execution of the company's business plan, strategic relationships, and the identification and realization of company product strategy and vision: leveraging cloud-based platforms to empower the healthcare industry’s data-driven transformation from volume-based to value-based models.

As Inovalon’s CEO, Dr. Dunleavy works extensively with a wide array of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insights and improvement. Dr. Dunleavy has led Inovalon from its origins to its current industry-leading position leveraging advanced, cloud-based data aggregation, analytics, point-of-care intervention, and data visualization technologies which are informed by data pertaining to more than 856,000 physicians, 375,000 clinical facilities, 158 million Americans, and 14 billion medical events. Together this comprises a powerful platform known as Inovalon ONE™ that enables high-value impact, improving actionable insight, clinical quality outcomes, and economics for health plans, ACOs, hospitals, physicians, pharmaceutical companies, device manufacturers, and patients.

Dr. Dunleavy received a Bachelor's degree in Biology modified with Engineering with High Honors from Dartmouth College where his studies and work focused upon the neurosciences, computer sciences and electrical engineering with his honors thesis focused on the computer simulation of artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced and was Board Certified in Internal Medicine. He serves as a Director on the Dartmouth Medical School Board of Overseers, has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, and has presented his work and materials at multiple national and international conferences.